NewsNation looks at a growing group taking unapproved substances marketed as brain peptides in hopes of better concentration.
Recap by typeshit. Full story at NewsNation.
The Form 483 cites microbial growth in a clean hood, reversed cleanroom air pressure and active ingredients marked for research use only. Check which pharmacy filled your vial.
One study cited by @fittrwithsquats put the risk of non-scarring hair loss about 40% higher with GLP-1 use, mostly telogen effluvium. Nail findings are less consistent.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
A short explainer for anyone adding peptide serums to their skincare and deciding whether copper peptides are worth using.
FDA adverse event data put semaglutide among the top five drugs tied to gallstones and cholecystitis, and pharmacists are urged to watch for early signs.
Loading…